![Maryjo Chamberlain-Tharp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maryjo Chamberlain-Tharp
Corporate Officer/Principal presso
NEUMORA THERAPEUTICS, INC.
Profilo
Maryjo Chamberlain-Tharp currently works at ARCH Venture Partners LLC, as Venture Partner from 2025 and Neumora Therapeutics, Inc., as Chief Business Officer from 2022.
Dr. Chamberlain-Tharp also formerly worked at Eli Lilly & Co., as Head-Neuroscience & East Coast Operations from 1997 to 2014 and AbbVie, Inc., as Global Head-Academic Outreach from 2014 to 2021.
Dr. Chamberlain-Tharp received his doctorate degree from Walden University LLC, undergraduate degree from Purdue University, and Masters Business Admin degree from Indiana University Bloomington.
Posizioni attive di Maryjo Chamberlain-Tharp
| Società | Posizione | Inizio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2021 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Investitore di Private Equity | 01/07/2025 |
Precedenti posizioni note di Maryjo Chamberlain-Tharp
| Società | Posizione | Fine |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2014 |
Formazione di Maryjo Chamberlain-Tharp
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Walden University LLC
 Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Indiana University Bloomington
 Indiana University Bloomington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
